Table 1.
Clinicopathological characteristics and GAS5 expression in 89 patient samples of gastric cancer
| Clinical parameter | Number of cases (%) |
|---|---|
|
Age (years) |
|
| <50 |
46 (51.7) |
| >50 |
43 (48.3.) |
|
Gender |
|
| Male |
53 (59.6) |
| Female |
36 (40.4) |
|
Location |
|
| Distal |
36 (40.4) |
| Middle |
35 (39.3) |
| Proximal |
18 (20.2) |
|
Size |
|
| >5 cm |
44 (49.4) |
| <5 cm |
45 (50.6) |
|
Histologic differentiation |
|
| Well |
6 (6.7) |
| Moderately |
30 (33.7) |
| Poorly |
43 (48.3) |
| Undifferentiatedly |
10 (11.2) |
|
Invasion depth |
|
| T1 |
21 (23.6) |
| T2 |
26 (29.2) |
| T3 |
23 (25.8) |
| T4 |
19 (21.3) |
|
TNM Stages |
|
| I |
15 (16.9) |
| II |
34 (38.2) |
| III |
35 (39.3) |
| IV |
5 (5.6) |
|
Lymphatic metastasis |
|
| Yes |
44 (49.4) |
| No |
45 (50.6) |
|
Regional lymph nodes |
|
| PN0 |
45 (50.6) |
| PN1 |
16 (18.0) |
| PN2 |
18 (20.2) |
| PN3 |
10 (11.2) |
|
Distant metastasis |
|
| Yes |
4 (4.5) |
| No |
85 (95.5) |
|
Expression of GAS5 |
|
| Low expression |
44 (49.4) |
| High expression | 45 (50.6) |